Skip to main content
Quest Diagnostics

SARS-CoV-2 mRNA Vaccination Affects Antibody and Cellular Immune Responses After B-Cell Depletion Therapies

European Committee for Treatment and Research in Multiple Sclerosis, 9th joint ECTRIMS-ACTRIMS meetings

ECTRIM 2023

Milan, Italy Oct 11-13, 2023

Poster presentation: SARS-CoV-2 mRNA vaccination affects antibody and cellular immune responses after B-cell depletion therapies

Authors: Asashima H, Kim D, Wang E, Lele N, Buitago-Pocasangre NC, Lutz R, Cruz I, Raddassi K, Ruff1 WE, Racke, MK Wilson JE, Givens TS, Grifoni A, Weiskopf D, Sette A, Kleinstein SH Montgomery RR, Shaw AC Li F,  Fan R, Hafler DA,  Tomayko MM,  Longbrake EE

Specialty: Infectious Disease, Neurology, COVID-19

Related content

Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Test FAQ
SARS CoV 2 Antibody Testing
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets

No Result Found.

    Close Filter OptionsFilter

      Our company

      Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

       

      Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.